Javascript must be enabled to continue!
Acute inflammation down‐regulates alpha‐synuclein expression in enteric neurons
View through CrossRef
AbstractThe protein alpha‐synuclein whose expression is strongly implicated in Parkinson's disease (PD) is not only expressed in the CNS but also in the enteric nervous system (ENS). The growing body of evidence suggesting that gastrointestinal inflammation is involved in the development of PD led us to investigate the effects of inflammation on alpha‐synuclein expression in primary culture of rat ENS and in mice with dextran sulfate sodium‐induced colitis. Using western blot and qPCR, we found that both lipopolysaccharide and a combination of tumor necrosis factor‐α and interleukin 1‐β decreased the expression levels of alpha‐synuclein in primary culture of rat ENS, an effect that was prevented in the presence of the p38 inhibitors SB203580 and BIRB 796. Lipopolysaccharide and tumor necrosis factor‐α/interleukin 1‐β had no effect on alpha‐synuclein expression in primary culture of rat CNS and in human erythroid leukemia cells. In mice, acute but not chronic dextran sulfate sodium‐induced colitis was associated with a decreased expression of colonic alpha‐synuclein. As a whole, our findings indicate that acute inflammatory insults down‐regulate alpha‐synuclein expression in the ENS via a p38 pathway. They provide new insights into the widely discussed concepts of alpha‐synuclein expression and aggregation in the ENS in PD and raise issues about the possible role of gastrointestinal inflammation in the development of PD.Open science badgesThis article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/.
image
Title: Acute inflammation down‐regulates alpha‐synuclein expression in enteric neurons
Description:
AbstractThe protein alpha‐synuclein whose expression is strongly implicated in Parkinson's disease (PD) is not only expressed in the CNS but also in the enteric nervous system (ENS).
The growing body of evidence suggesting that gastrointestinal inflammation is involved in the development of PD led us to investigate the effects of inflammation on alpha‐synuclein expression in primary culture of rat ENS and in mice with dextran sulfate sodium‐induced colitis.
Using western blot and qPCR, we found that both lipopolysaccharide and a combination of tumor necrosis factor‐α and interleukin 1‐β decreased the expression levels of alpha‐synuclein in primary culture of rat ENS, an effect that was prevented in the presence of the p38 inhibitors SB203580 and BIRB 796.
Lipopolysaccharide and tumor necrosis factor‐α/interleukin 1‐β had no effect on alpha‐synuclein expression in primary culture of rat CNS and in human erythroid leukemia cells.
In mice, acute but not chronic dextran sulfate sodium‐induced colitis was associated with a decreased expression of colonic alpha‐synuclein.
As a whole, our findings indicate that acute inflammatory insults down‐regulate alpha‐synuclein expression in the ENS via a p38 pathway.
They provide new insights into the widely discussed concepts of alpha‐synuclein expression and aggregation in the ENS in PD and raise issues about the possible role of gastrointestinal inflammation in the development of PD.
Open science badgesThis article has received a badge for *Open Materials* because it provided all relevant information to reproduce the study in the manuscript.
The complete Open Science Disclosure form for this article can be found at the end of the article.
More information about the Open Practices badges can be found at https://cos.
io/our-services/open-science-badges/.
image.
Related Results
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
Characterization and Regulation of Alpha‐Synuclein Phosphorylation in Enteric Neurons
ABSTRACT
Alpha‐synuclein is a 140 aa neuronal protein pathologically and genetically linked to Parkinson's disease (PD). In PD, the major pro...
Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
Characterization and regulation of alpha-synuclein phosphorylation in enteric neurons under physiological conditions
Alpha-synuclein is a 140 aa neuronal protein pathologically and
genetically linked to Parkinson’s disease (PD). In PD, the major protein
modification of alpha-synuclein is phosphor...
Un manoscritto equivocato del copista santo Theophilos († 1548)
Un manoscritto equivocato del copista santo Theophilos († 1548)
<p><font size="3"><span class="A1"><span style="font-family: 'Times New Roman','serif'">ΕΝΑ ΛΑΝ&...
Comparison of commercially available antibodies for the detection of phosphorylated alpha‐synuclein in primary culture of ENS
Comparison of commercially available antibodies for the detection of phosphorylated alpha‐synuclein in primary culture of ENS
Abstract
Background
It is now well established that phosphorylated alpha‐synuclein histopathology, the pathologic hallmar...
Novel β-synuclein Rearrangements in tumor
Novel β-synuclein Rearrangements in tumor
Abstract
Purpose
The synuclein family includes a-, b-, g-synuclein and is predominantly expressed in neurons. a- and b-synuclein is mutated in Parkinson's disease and demen...
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
Clinical stage Alzheimer’s therapy, NNI‐362 promotes TH+ neurons associated with a reversal of motor deficits in AAV‐alpha synuclein model, leaving alpha synuclein unchanged
AbstractBackgroundNNI‐362 is a novel small molecule identified by phenotypic screening to discover compounds that promote new neurons from human neural progenitor cells and have ne...
Stimulator of interferon genes (STING) expression in the enteric nervous system and contributions of glial STING in disease
Stimulator of interferon genes (STING) expression in the enteric nervous system and contributions of glial STING in disease
AbstractBackgroundAppropriate host–microbe interactions are essential for enteric glial development and subsequent gastrointestinal function, but the potential mechanisms of microb...

